Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids

2Firsts Events by 2FIRSTS Leona Zhu, edited by Sophia
Apr.06.2024
Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids
Rise of refillable e-cigarette products in European market since 2023, UK bans disposable e-cigarettes, e-liquids become popular.

Since 2023, there has been a trend of rising popularity in Europe's e-cigarette market for refillable products. In January 2024, the UK announced a ban on disposable e-cigarettes, sparking a growing interest in e-liquid products. At the recent EVO NXT tobacco exhibition in Spain, 2FIRSTS also observed a significant increase in exhibitors showcasing refillable products and e-liquid products.

 

In addition, at the expo, the newly popular mainstream brand GOLD BAR released pod system and e-liquid products; the well-known American brand TYSON also showcased its e-liquid products.

 

Below are the e-liquid products and pod systems showcased on EVO NXT (Note: The following list is not exhaustive, all images are provided by 2FIRSTS).

 

Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids
E-liquid products from GOLG BAR

 

Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids
TYSON's e-liquid products

 

 

Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids
ONE PUFF e-liquid products

 

Roundup of E-Liquids and Pod-Systems at EVO NXT: GOLD BAR, TYSON Unveil E-Liquids
MUSS's e-liquid products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
GOLG BAR's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
ELFBAR's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
Aroma King's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
Firstunion's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
Dejavoo's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
Dejavoo's pod-system products

 

GOLD BAR和TYSON品牌推出烟油产品 盘点EVO NXT展上的烟油及换弹式电子烟
CHARLIE LOVERS' pod-system products

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10